STRM vs. CNGL, CREX, ARBB, VRME, EBIXQ, SLE, OMQS, HCTI, KBNT, and TZOO
Should you be buying Streamline Health Solutions stock or one of its competitors? The main competitors of Streamline Health Solutions include Canna-Global Acquisition (CNGL), Creative Realities (CREX), ARB IOT Group (ARBB), VerifyMe (VRME), Ebix (EBIXQ), Super League Enterprise (SLE), OMNIQ (OMQS), Healthcare Triangle (HCTI), Kubient (KBNT), and Travelzoo (TZOO).
Canna-Global Acquisition (NASDAQ:CNGL) and Streamline Health Solutions (NASDAQ:STRM) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, community ranking, profitability, analyst recommendations, risk, dividends and earnings.
Canna-Global Acquisition has higher earnings, but lower revenue than Streamline Health Solutions.
Streamline Health Solutions received 224 more outperform votes than Canna-Global Acquisition when rated by MarketBeat users.
In the previous week, Streamline Health Solutions had 2 more articles in the media than Canna-Global Acquisition. MarketBeat recorded 2 mentions for Streamline Health Solutions and 0 mentions for Canna-Global Acquisition. Canna-Global Acquisition's average media sentiment score of 0.22 beat Streamline Health Solutions' score of 0.00 indicating that Streamline Health Solutions is being referred to more favorably in the news media.
Canna-Global Acquisition has a beta of 0.02, suggesting that its share price is 98% less volatile than the S&P 500. Comparatively, Streamline Health Solutions has a beta of 1.58, suggesting that its share price is 58% more volatile than the S&P 500.
19.6% of Canna-Global Acquisition shares are owned by institutional investors. Comparatively, 31.7% of Streamline Health Solutions shares are owned by institutional investors. 72.1% of Canna-Global Acquisition shares are owned by insiders. Comparatively, 29.5% of Streamline Health Solutions shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Canna-Global Acquisition has a net margin of 0.00% compared to Canna-Global Acquisition's net margin of -82.75%. Streamline Health Solutions' return on equity of 0.00% beat Canna-Global Acquisition's return on equity.
Streamline Health Solutions has a consensus price target of $2.00, suggesting a potential upside of 334.78%. Given Canna-Global Acquisition's higher probable upside, analysts clearly believe Streamline Health Solutions is more favorable than Canna-Global Acquisition.
Summary
Streamline Health Solutions beats Canna-Global Acquisition on 7 of the 11 factors compared between the two stocks.
Get Streamline Health Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for STRM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding STRM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Streamline Health Solutions Competitors List
Related Companies and Tools
